Nymox Pharmaceutical
NYMX
#9607
Rank
A$27.48 M
Marketcap
Country
$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.35 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$9.83 Million, an increase over its 2021 earnings that were of -A$18.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.35 Million-65.96%
2022 -A$9.83 Million-47.71%
2021 -A$18.8 Million6.61%
2020 -A$17.63 Million-10.91%
2019 -A$19.79 Million24.24%
2018 -A$15.93 Million-20.03%
2017 -A$19.92 Million2.71%
2016 -A$19.39 Million-63.86%
2015 -A$53.66 Million674.44%
2014 -A$6.93 Million-6.11%
2013 -A$7.38 Million-35.66%
2012 -A$11.48 Million-20.76%
2011 -A$14.48 Million38.33%
2010 -A$10.47 Million35.59%
2009 -A$7.72 Million11.8%
2008 -A$6.91 Million-12.94%
2007 -A$7.93 Million8.85%
2006 -A$7.29 Million36.5%
2005 -A$5.34 Million-4.4%
2004 -A$5.59 Million-14.58%
2003 -A$6.54 Million
2001 -A$4.8 Million-20.54%
2000 -A$6.04 Million21.72%
1999 -A$4.96 Million-25.56%
1998 -A$6.66 Million101.3%
1997 -A$3.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$10.20 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.83 Billion 55,985.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.67 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.28 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.70 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA